NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/02/2025
Voltar para busca
Dado oficial do USPTO
PROTEINA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PROTEINA
ST13
US500000097655467Classe
9, 10, 42, 44
Pedido
97655467
Registro
7700523
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
25/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 42, 44
Data de depósito
31/10/2022
Data de registro
25/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/02/2025
Última transação
25/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Primeiro uso
05/08/2015
Primeiro uso no comércio
16/12/2020
Código do desenho
4
Tipo de titular
03
Localização do titular
Seoul, KR
Examinador
HENRY, NAKIA D
Unidade examinadora
O20
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Proteina Co., Ltd.
Representantes
Hun Joon Kim LEX IP MEISTER, PLLC.
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Biochip for research or scientific purposes; Biochip analyzing apparatusoptical imaging apparatus and instruments in conjunction with biochip for use in the study of proteinspeptidesDNAaptamerRNAnot for medical purposes; Biochip sensors for research or scientific purposes; Cell chip inspection devicesbio-cell chips for research or scientific purposes; Diagnostic apparatus for the detection of biomarkers for laboratory or research use; Protein analysis devicesscientific apparatus and instruments for analyzing protein; Laboratory apparatus for analyzing biological pharmaceuticals; Scientific instruments for analyzing chemical and biological substances for the presenceabsencequantity of target biologics and chemicals; Optical imaging apparatus and instruments for use in the study of proteinspeptidesDNAaptamerRNAnot for medical purposes; Biosensorssensors for the purpose of scientific and diagnostic use for detecting the presence of multiple molecular substances; Diagnostic apparatus for the detection of proteinsDNAcellsnot for medical purpose; Downloadable and recorded computer software for use in database generationanalysismanagement; Downloadable and recorded computer software for use in optical image and scientific data analysis; Downloadable images in the field of in vitro diagnosticsnamely fluorescence images used for in vitro diagnostics; Analyzers for analyzing immunological activity for scientific purposes; Downloadable images in the field of in vitro diagnosticsnamely fluorescence images used for in vitro diagnostics
Classe 10
Analyzers for analyzing immunological activity for medical purposes; Analyzers for analyzing immunological activity for medical purposes; Medical apparatus and instrument for diagnostic usefor medical diagnostic testing in the fields of cell-based testing; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for analyzing drug compounds; Immunoassay apparatus for detecting and analyzing biomarkers for medical diagnoses; Medical diagnostic apparatus for testing genomic materialsproteinscells relevant to diseases; Medical instruments for analyzing and identifying genomic materialsproteinscells; Medical diagnostic apparatus and instruments for detecting and analyzing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Apparatus for medicalclinicaldiagnostic uses by analyzing genomic materialsproteinscells related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals; Computer displays and computer monitors and controllers used in direct association with medical diagnosis apparatuses during the process of diagnosis of a conditionnamely genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals in an individual; Immunochemical testing apparatus for analyzing genomic materialsproteinscells for medical use; Automatic analyzers for disease diagnosis through inspection of genomic materialsproteinsbio-samples for medical purposes; Apparatus for testing genomic materialsproteinscells relevant to diseases for medical purposes; Medical apparatus for testing genomic materialsproteinscells relevant to diseasesnamely cancer and inflammatory disease; Apparatus for analyzing images for medical usefluorescence imaging apparatus for medical purpose; Medical diagnostic apparatus for analyzing and measuring genomic materialsproteinsbio-samples; In vitro medical diagnostic devices for molecularly characterizing diseases related to genetic abnormalityprotein abnormalityabnormal expression of proteinsabnormality in protein interaction signals
Classe 42
Conducting early evaluation of new pharmaceutical compounds in development by others; Discovery and development of new drug candidate material; Scientific research for medical purposes in the area of cancerous diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical product evaluationtechnical assessment of the efficiency of pharmaceuticals; Medical research laboratory services for predicting disease; Pharmaceutical testing; Pharmaceutical research services; Provision of information regarding testinginspectionresearch of pharmaceutical products; Pharmaceutical product evaluation; Scientific research into medicinehealthpharmacology; Human tissue analysis for the purpose of medical research; Design of devices intended for protein analysis; Protein analysis; Development of devices intended for protein analysis; Scientific and technological servicesscientific research in the field of biopharmaceuticals; Development of medical diagnostic instruments; Technological research in the field of biopharmaceuticals; Technical data analysis services for genomic and proteomic materials; Materials analysis; Development of computer software for big data processing; Biomedical research services; Biological research; Pharmaceutical research and development; Medical and scientific researchconducting clinical trials by proxy; Medical and scientific researchconducting clinical studies of medicines for others; Pharmaceutical product evaluation; Scientific research services for medical purposes; Design of medical diagnostic apparatus and instruments; Development of computer software for use with medical equipment; Laboratory research services relating to pharmaceuticals; Design and development of image processing software; Medical analysis services relevant to drug developmentlaboratory testingscientific research; Providing medical and scientific research information services relating to pharmaceuticals and medical products in the fields of pharmaceuticals and genetics; Medical laboratory services for the analysis of samples taken from patients
Classe 44
Medical analysis for the diagnosis and treatment of persons; Medical analysis services for cancer diagnosis and prognosis; Provision of information regarding cancer preventionscreeningdiagnosistreatment; Medical analysis services relating to cancer diagnoses; Analysis of human biometric data for medical purposes; Medical analysis services relevant to diagnoses; Medical information services relating to pharmaceuticals and medical products; Providing information services relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals for pharmaceuticals and medical products; Medical diagnostic services for testing and analysis; Analysis of human tissue for medical treatment; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Clinical medical consultation servicescollectingreviewinganalyzingreporting clinical data; Medical analysis services relating to treatment of patients
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
25/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2025
PUBO
PUBLISHED FOR OPPOSITION
07/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/11/2024
IUAA
USE AMENDMENT ACCEPTED
27/11/2024
ALIE
ASSIGNED TO LIE
06/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/08/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/08/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/02/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
20/02/2024
IUAF
USE AMENDMENT FILED
20/02/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
20/02/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
20/11/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
20/11/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/08/2023
GNRT
NON-FINAL ACTION E-MAILED
21/08/2023
CNRT
NON-FINAL ACTION WRITTEN
21/08/2023
DOCK
ASSIGNED TO EXAMINER
14/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/11/2022
NWAP
NEW APPLICATION ENTERED
03/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PROTEINA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.